Abstract
Prostate cancer is the most common form of cancer in American men other than skin cancer. The American Cancer Society had estimated that about 185,000 new cases of prostate cancer would have been diagnosed by 2008 in the USA alone. Almost 30,000 men will die of the disease in 2008 alone in this country. It is the second leading cause of cancer death in men after lung cancer. While a man has a 15% chance of being diagnosed with prostate cancer during his lifetime, only 3% actually dies of the disease. The use of PSA as a screening tool has resulted in a far greater number of men being diagnosed with prostate cancer at the earliest stages. Thus, in the modern era, the vast majority of men live for a long time after diagnosis and treatment. This has translated into younger men being diagnosed with prostate cancer and long-term sexual function becoming an even bigger issue given these factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fowler, F. J., Barry, M. J., Lu-Yao, G., Roman, A., Wasson, J., & Wennberg, J. E. (1993). Patient-reported complications and follow-up treatment after radical prostatectomy. Urology, 42, 622–629.
Kundu, S. D., Roehl, K. A., Eggener, S. E., Antenor, J. A., Han, M., & Catalona, W. J. (2004). Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. Journal d’Urologie, 172, 2227–2231.
Menon, M., Shrivastava, A., Kaul, S., et al. (2007). Vattikuti Institute prostatectomy: Contemporary technique and analysis of results. European Urology, 51, 648–657. Discussion 57–58.
Stanford, J. L., Feng, Z., Hamilton, A. S., et al. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. The Journal of the American Medical Association, 283, 354–360.
Walsh, P. C., Marschke, P., Ricker, D., & Burnett, A. L. (2000). Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology, 55, 58–61.
Rabbani, F., Stapleton, A. M. F., Kattan, M. W., et al. (2000). Factors predicting recovery of erections after radical prostatectomy. Journal d’Urologie, 164, 1929–1934.
Masterson, T. A., Serio, A. M., Mulhall, J. P., Vickers, A. J., & Eastham, J. A. (2008). Modified technique for neurovascular bundle preservation during radical prostatectomy: Association between technique and recovery of erectile function. BJU International, 101(10), 1217–1222.
User, H. M., Hairston, J. H., Zelner, D. J., McKenna, K. E., & McVary, K. T. (2003). Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. Journal d’Urologie, 169, 1175–1179.
Mullerad, M., Donohue, J. F., Li, P. S., Scardino, P. T., & Mulhall, J. P. (2006). Functional sequelae of cavernous nerve injury in the rat: Is there model dependency. The Journal of Sexual Medicine, 3, 77–83.
Leungwattanakij, S., Bivalacqua, T. J., Usta, M. F., et al. (2003). Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. Journal of Andrology, 24, 239–245.
Klein, L. T., Miller, M. I., Buttyan, R., et al. (1997). Apoptosis in the rat penis after penile denervation. Journal d’Urologie, 158, 626–630.
Benoit, G., Droupy, S., Quillard, J., Paradis, V., & Giuliano, F. (1999). Supra and infralevator neurovascular pathways to the penile corpora cavernosa. Journal of Anatomy, 195(Pt 4), 605–615.
Breza, J., Aboseif, S. R., Orvis, B. R., Lue, T. F., & Tanagho, E. A. (1989). Detailed anatomy of penile neurovascular structures: Surgical significance. Journal d’Urologie, 141, 437–443.
Droupy, S., Hessel, A., Benoit, G., Blanchet, P., Jardin, A., & Giuliano, F. (1999). Assessment of the functional role of accessory pudendal arteries in erection by transrectal color Doppler ultrasound. Journal d’Urologie, 162, 1987–1991.
Polascik, T. J., & Walsh, P. C. (1995). Radical retropubic prostatectomy: The influence of accessory pudendal arteries on the recovery of sexual function. Journal d’Urologie, 154, 150–152.
Rogers, C. G., Trock, B. P., & Walsh, P. C. (2004). Preservation of accessory pudendal arteries during radical retropubic prostatectomy: Surgical technique and results. Urology, 64, 148–151.
Secin, F., Karanikolas, N., Touijer, K., Martinez Salamanca, J. I., Vickers, A., & Guillonneau, B. (2005). Anatomy of accessory pudendal arteries in laparoscopic radical prostatectomy. The Journal of Urology, 174(2), 523–526.
Moreland, R. B., Albadawi, H., Bratton, C., et al. (2001). O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle. American Journal of Physiology. Heart and Circulatory Physiology, 281, H552–H558.
Moreland, R. B., Gupta, S., Goldstein, I., & Traish, A. (1998). Cyclic AMP modulates TGF-beta 1-induced fibrillar collagen synthesis in cultured human corpus cavernosum smooth muscle cells. International Journal of Impotence Research, 10, 159–163.
Muller, A., Tal, R., Donohue, J. F., et al. (2008). The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. The Journal of Sexual Medicine, 5, 562–570.
Wayman, C. (2008). Unpublished Data.
Nehra, A., Goldstein, I., Pabby, A., et al. (1996). Mechanisms of venous leakage: A prospective clinicopathological correlation of corporeal function and structure. Journal d’Urologie, 156, 1320–1329.
Iacono, F., Giannella, R., Somma, P., Manno, G., Fusco, F., & Mirone, V. (2005). Histological alterations in cavernous tissue after radical prostatectomy. Journal d’Urologie, 173, 1673–1676.
Mulhall, J. P., & Graydon, R. J. (1996). The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. International Journal of Impotence Research, 8, 91–94.
Mulhall, J. P., Slovick, R., Hotaling, J., et al. (2002). Erectile dysfunction after radical prostatectomy: Hemodynamic profiles and their correlation with the recovery of erectile function. Journal d’Urologie, 167, 1371–1375.
Ferrini, M. G., Davila, H. H., Kovanecz, I., Sanchez, S. P., Gonzalez-Cadavid, N. F., & Rajfer, J. (2006). Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology, 68, 429–435.
Kovanecz, I., Rambhatla, A., Ferrini, M., et al. (2008). Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. International Journal of Impotence Research, 20, 202–212.
Kovanecz, I., Rambhatla, A., Ferrini, M. G., et al. (2008). Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU International, 101, 203–210.
Lysiak, J. J., Yang, S. K., Klausner, A. P., Son, H., Tuttle, J. B., & Steers, W. D. (2008). Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. Journal d’Urologie, 179, 779–785.
Vignozzi, L., Filippi, S., Luconi, M., et al. (2004). Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology, 145, 1823–1834.
Mulhall, J. P., Muller, A., Donohue, J. F., et al. (2008). The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. The Journal of Sexual Medicine, 5, 1126–1136.
Mueller, A., & Mulhall, J. P. (2007). Unpublished data.
Mulhall, J. P., & Morgentaler, A. (2007). Penile rehabilitation should become the norm for radical prostatectomy patients. The Journal of Sexual Medicine, 4, 538–543.
Montorsi, F., Guazzoni, G., Strambi, L. F., et al. (1997). Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. Journal d’Urologie, 158, 1408–1410.
Mulhall, J., Land, S., Parker, M., Waters, W. B., & Flanigan, R. C. (2005). The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. The Journal of Sexual Medicine, 2, 532–540. Discussion 40–42.
Padma-Nathan, H., McCullough, A., Giuliano, F., et al. (2008). Nightly post-operative sildenafil dramatically improves the return of spontaneous erections following a bilateral nerve-sparing radical prostatectomy. Int J Impot Res, 20, 479–486.
Desouza, C., Parulkar, A., Lumpkin, D., Akers, D., & Fonseca, V. A. (2002). Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care, 25, 1336–1339.
Rosano, G. M., Aversa, A., Vitale, C., Fabbri, A., Fini, M., & Spera, G. (2005). Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. European Urology, 47, 214–220. Discussion 20–22.
Zhang, L., Zhang, Z., Zhang, R. L., et al. (2006). Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Research, 1118, 192–198.
Zhang, R., Wang, Y., Zhang, L., et al. (2002). Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke, 33, 2675–2680.
Schwartz, E. J., Wong, P., & Graydon, R. J. (2004). Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. Journal d’Urologie, 171, 771–774.
Bannowsky, A., & Junemann, K. P. (2008). Unpublished data.
Bosshardt, R. J., Farwerk, R., Sikora, R., Sohn, M., & Jakse, G. (1995). Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. British Journal of Urology, 75, 786–791.
Raina, R., Agarwal, A., Ausmundson, S., et al. (2006). Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. International Journal of Impotence Research, 18, 77–81.
Dalkin, B. L., & Christopher, B. A. (2007). Preservation of penile length after radical prostatectomy: Early intervention with a vacuum erection device. International Journal of Impotence Research, 19, 501–504.
Kohler, T. S., Pedro, R., Hendlin, K., et al. (2007). A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU International, 100, 858–862.
Costabile, R. A., Spevak, M., Fishman, I. J., et al. (1998). Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. Journal d’Urologie, 160, 1325–1328.
Raina, R., Agarwal, A., Zaramo, C. E., Ausmundson, S., Mansour, D., & Zippe, C. D. (2005). Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. International Journal of Impotence Research, 17, 86–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mulhall, J.P. (2011). The Effect of Radical Prostatectomy on Erectile Dysfunction. In: McVary, K. (eds) Contemporary Treatment of Erectile Dysfunction. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-536-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-60327-536-1_15
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-535-4
Online ISBN: 978-1-60327-536-1
eBook Packages: MedicineMedicine (R0)